Pluripotent Stem Cell‐Engineered Cell Sheets Reassembled with Defined Cardiovascular Populations Ameliorate Reduction in Infarct Heart Function Through Cardiomyocyte‐Mediated Neovascularization

Although stem cell therapy is a promising strategy for cardiac restoration, the heterogeneity of transplanted cells has been hampering the precise understanding of the cellular and molecular mechanisms. Previously, we established a cardiovascular cell differentiation system from mouse pluripotent stem cells, in which cardiomyocytes (CMs), endothelial cells (ECs), and mural cells (MCs) can be systematically induced and purified. Combining this with cell sheet technology, we generated cardiac tissue sheets reassembled with defined cardiovascular populations. Here, we show the potentials and mechanisms of cardiac tissue sheet transplantation in cardiac function after myocardial infarction (MI). Transplantation of the cardiac tissue sheet to a rat MI model showed significant and sustained improvement of systolic function accompanied by neovascularization. Reduction of the infarct wall thinning and fibrotic length indicated the attenuation of left ventricular remodeling. Cell tracing with species‐specific fluorescent in situ hybridization after transplantation revealed a relatively early loss of transplanted cells and an increase in endogenous neovascularization in the proximity of the graft, suggesting an indirect angiogenic effect of cardiac tissue sheets rather than direct CM contributions. We prospectively dissected the functional mechanisms with cell type‐controlled sheet analyses. Sheet CMs were the main source of vascular endothelial growth factor. Transplantation of sheets lacking CMs resulted in the disappearance of neovascularization and subsequent functional improvement, indicating that the beneficial effects of the sheet were achieved by sheet CMs. ECs and MCs enhanced the sheet functions and structural integration. Supplying CMs to ischemic regions with cellular interaction could be a strategic key in future cardiac cell therapy. STEM CELLS2012;30:1196–1205

[1]  T. Okano,et al.  A novel recovery system for cultured cells using plasma-treated polystyrene dishes grafted with poly(N-isopropylacrylamide). , 1993, Journal of biomedical materials research.

[2]  S. Nishikawa,et al.  Prospective identification of cardiac progenitors by a novel single cell‐based cardiomyocyte induction , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[3]  Stefanie Dimmeler,et al.  Mechanism of Improved Cardiac Function After Bone Marrow Mononuclear Cell Therapy: Role of Cardiovascular Lineage Commitment , 2010, Circulation.

[4]  S. Gronthos,et al.  Concise Review: Mesenchymal Stromal Cells: Potential for Cardiovascular Repair , 2008, Stem cells.

[5]  M. Tendera,et al.  Intracoronary infusion of bone marrow-derived selected CD34+CXCR4+ cells and non-selected mononuclear cells in patients with acute STEMI and reduced left ventricular ejection fraction: results of randomized, multicentre Myocardial Regeneration by Intracoronary Infusion of Selected Population of Stem , 2009, European heart journal.

[6]  Tadao Serikawa,et al.  Generation of Knockout Rats with X-Linked Severe Combined Immunodeficiency (X-SCID) Using Zinc-Finger Nucleases , 2010, PloS one.

[7]  W. Hornebeck.  Down-regulation of tissue inhibitor of matrix metalloprotease-1 (TIMP-1) in aged human skin contributes to matrix degradation and impaired cell growth and survival. , 2003, Pathologie-biologie.

[8]  Mark F. Lythgoe,et al.  De novo cardiomyocytes from within the activated adult heart after injury , 2011, Nature.

[9]  Jun Yamashita,et al.  Flk1-positive cells derived from embryonic stem cells serve as vascular progenitors , 2000, Nature.

[10]  R. Weisel,et al.  Optimal time for cardiomyocyte transplantation to maximize myocardial function after left ventricular injury. , 2001, The Annals of thoracic surgery.

[11]  T. Okano,et al.  Composite Cell Sheets: A Further Step Toward Safe and Effective Myocardial Regeneration by Cardiac Progenitors Derived From Embryonic Stem Cells , 2010, Circulation.

[12]  T. Watabe,et al.  Enhancement of vascular progenitor potential by protein kinase A through dual induction of Flk-1 and Neuropilin-1. , 2009, Blood.

[13]  M. Zile,et al.  Accelerated LV remodeling after myocardial infarction in TIMP-1-deficient mice: effects of exogenous MMP inhibition. , 2005, American journal of physiology. Heart and circulatory physiology.

[14]  Teruo Okano,et al.  Transplantation of cardiac progenitor cells ameliorates cardiac dysfunction after myocardial infarction in mice. , 2009, The Journal of clinical investigation.

[15]  E. Sonnenblick,et al.  Cellular basis of chronic ventricular remodeling after myocardial infarction in rats. , 1991, Circulation research.

[16]  S M Schwartz,et al.  Skeletal myoblast transplantation for repair of myocardial necrosis. , 1996, The Journal of clinical investigation.

[17]  Shinya Yamanaka,et al.  Efficient and Scalable Purification of Cardiomyocytes from Human Embryonic and Induced Pluripotent Stem Cells by VCAM1 Surface Expression , 2011, PloS one.

[18]  富田 伸司.  Autologous Transplantation of Bone Marrow Cells Improves Damaged Heart Function , 2000 .

[19]  T. Couffinhal,et al.  Regulation of endothelial cell cytoskeletal reorganization by a secreted frizzled-related protein-1 and frizzled 4- and frizzled 7-dependent pathway: role in neovessel formation. , 2008, The American journal of pathology.

[20]  D. Srivastava,et al.  Cardiac fibroblasts regulate myocardial proliferation through beta1 integrin signaling. , 2009, Developmental cell.

[21]  S. Nishikawa,et al.  Adrenomedullin/Cyclic AMP Pathway Induces Notch Activation and Differentiation of Arterial Endothelial Cells From Vascular Progenitors , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[22]  E. Braunwald,et al.  Myocardial reperfusion, limitation of infarct size, reduction of left ventricular dysfunction, and improved survival. Should the paradigm be expanded? , 1989, Circulation.

[23]  E. Seifried,et al.  Transcoronary Transplantation of Functionally Competent BMCs Is Associated With a Decrease in Natriuretic Peptide Serum Levels and Improved Survival of Patients With Chronic Postinfarction Heart Failure: Results of the TOPCARE-CHD Registry , 2007, Circulation research.

[24]  Hidezo Mori,et al.  Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarction , 2006, Nature Medicine.

[25]  K. Chien,et al.  Regenerative medicine and human models of human disease , 2008, Nature.

[26]  David M. Bodine,et al.  Bone marrow cells regenerate infarcted myocardium , 2001, Nature.

[27]  H. Matsubara,et al.  Controlled delivery of basic fibroblast growth factor promotes human cardiosphere-derived cell engraftment to enhance cardiac repair for chronic myocardial infarction. , 2008, Journal of the American College of Cardiology.

[28]  Hideki Uosaki,et al.  Directed and Systematic Differentiation of Cardiovascular Cells From Mouse Induced Pluripotent Stem Cells , 2008, Circulation.

[29]  P. Doevendans,et al.  Intracoronary infusion of mononuclear cells from bone marrow or peripheral blood compared with standard therapy in patients after acute myocardial infarction treated by primary percutaneous coronary intervention: results of the randomized controlled HEBE trial. , 2011, European heart journal.

[30]  Takayuki Asahara,et al.  Isolation of Putative Progenitor Endothelial Cells for Angiogenesis , 1997, Science.

[31]  Hideki Uosaki,et al.  Cyclosporin-A potently induces highly cardiogenic progenitors from embryonic stem cells. , 2009, Biochemical and biophysical research communications.

[32]  Y. Yoon,et al.  Role of host tissues for sustained humoral effects after endothelial progenitor cell transplantation into the ischemic heart , 2007, The Journal of experimental medicine.

[33]  E. Diethrich,et al.  One-year follow-up of feasibility and safety of the first U.S., randomized, controlled study using 3-dimensional guided catheter-based delivery of autologous skeletal myoblasts for ischemic cardiomyopathy (CAuSMIC study). , 2009, JACC. Cardiovascular interventions.

[34]  K. Segawa,et al.  The Significant Cardiomyogenic Potential of Human Umbilical Cord Blood‐Derived Mesenchymal Stem Cells In Vitro , 2007, Stem cells.

[35]  K. Bendixen,et al.  Physiological function and transplantation of scaffold-free and vascularized human cardiac muscle tissue , 2009, Proceedings of the National Academy of Sciences.

[36]  M. Komeda,et al.  Initial Effects of the Left Ventricular Repair by Plication May Not Last Long in a Rat Ischemic Cardiomyopathy Model , 2001, Circulation.

[37]  M. Gnecchi,et al.  Paracrine mechanisms of stem cell reparative and regenerative actions in the heart. , 2011, Journal of molecular and cellular cardiology.

[38]  Stephan Rohr,et al.  Electrotonic Modulation of Cardiac Impulse Conduction by Myofibroblasts , 2006, Circulation research.

[39]  Hideki Uosaki,et al.  Induction and Enhancement of Cardiac Cell Differentiation from Mouse and Human Induced Pluripotent Stem Cells with Cyclosporin-A , 2011, PloS one.

[40]  Masayuki Yamato,et al.  Endothelial Cell Coculture Within Tissue-Engineered Cardiomyocyte Sheets Enhances Neovascularization and Improves Cardiac Function of Ischemic Hearts , 2008, Circulation.

[41]  R. Weisel,et al.  Autologous transplantation of bone marrow cells improves damaged heart function. , 1999, Circulation.

[42]  D. Srivastava,et al.  Thymosin β4 activates integrin-linked kinase and promotes cardiac cell migration, survival and cardiac repair , 2004, Nature.

[43]  Pál Pacher,et al.  Measurement of cardiac function using pressure–volume conductance catheter technique in mice and rats , 2008, Nature Protocols.

[44]  E. Marbán,et al.  Expansion of human cardiac stem cells in physiological oxygen improves cell production efficiency and potency for myocardial repair. , 2011, Cardiovascular research.

[45]  A. Zeiher,et al.  Clinical Outcome 2 Years After Intracoronary Administration of Bone Marrow–Derived Progenitor Cells in Acute Myocardial Infarction , 2010, Circulation. Heart failure.

[46]  S. Homma,et al.  Neovascularization of ischemic myocardium by human bone-marrow–derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function , 2001, Nature Medicine.

[47]  O. Alfieri,et al.  The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) Trial: First Randomized Placebo-Controlled Study of Myoblast Transplantation , 2008, Circulation.

[48]  M. Pfeffer,et al.  Ventricular Remodeling After Myocardial Infarction: Experimental Observations and Clinical Implications , 1990, Circulation.

[49]  K. Poh,et al.  Intramyocardial Transplantation of Autologous CD34+ Stem Cells for Intractable Angina: A Phase I/IIa Double-Blind, Randomized Controlled Trial , 2007, Circulation.

[50]  Hiroshi Sato,et al.  Intracoronary Administration of Cardiac Progenitor Cells Alleviates Left Ventricular Dysfunction in Rats With a 30-Day-Old Infarction , 2010, Circulation.

[51]  F. Prósper,et al.  Adult Stem Cells: From New Cell Sources to Changes in Methodology , 2011, Journal of cardiovascular translational research.

[52]  A. Hatzopoulos,et al.  Stem cell therapy for cardiac repair: benefits and barriers , 2009, Expert Reviews in Molecular Medicine.

[53]  H. Huikuri,et al.  Effects of intracoronary injection of mononuclear bone marrow cells on left ventricular function, arrhythmia risk profile, and restenosis after thrombolytic therapy of acute myocardial infarction. , 2008, European heart journal.

[54]  T. Okano,et al.  Three-dimensional cell-dense constructs containing endothelial cell-networks are an effective tool for in vivo and in vitro vascular biology research. , 2010, Microvascular research.

[55]  Andreas Hess,et al.  Engineered heart tissue grafts improve systolic and diastolic function in infarcted rat hearts , 2006, Nature Medicine.

[56]  Subbiah Vairamuthu,et al.  Time course studies on the initiation of complement activation in acute myocardial infarction induced by coronary artery ligation in rats , 2005, Molecular and Cellular Biochemistry.

[57]  D. Young,et al.  Species-specific in situ hybridization with fluorochrome-labeled DNA probes to study vascularization of human skin grafts on athymic mice. , 1996, The Journal of burn care & rehabilitation.

[58]  DaisukeTaura,et al.  Induction and Isolation of Vascular Cells From Human Induced Pluripotent Stem Cells—Brief Report , 2009 .

[59]  Giulio Cossu,et al.  Isolation and Expansion of Adult Cardiac Stem Cells From Human and Murine Heart , 2004, Circulation research.

[60]  Ralf Kettenhofen,et al.  Engraftment of engineered ES cell–derived cardiomyocytes but not BM cells restores contractile function to the infarcted myocardium , 2006, The Journal of experimental medicine.

[61]  M. Komeda,et al.  Combined Procedure of Surgical Repair and Cell Transplantation for Left Ventricular Aneurysm: An Experimental Study , 2002, Circulation.

[62]  P. Menasché.  Cardiac cell therapy: lessons from clinical trials. , 2011, Journal of molecular and cellular cardiology.